Aim Around one-third of patients with Crohn's disease are affected by Crohn's fistula-in-ano (pCD). It typically follows a chronic course and patients undergo longterm medical and surgical therapy. We set out to describe current surgical practice in the management of pCD in the UK.
Introduction
Perianal disease affects an estimated 34% of patients with Crohn's disease, with a Crohn's fistula-in-ano occurring in around 60% of patients [1, 2] . Perianal fistulating disease (pCD) represents a significant challenge for patients, physicians and surgeons. Despite advances in treatment, long-term remission will only be achieved for two-thirds of patients with simple fistulas and just a third of patients with complex fistulas [3] .
Due to the paucity of large-scale, well-designed, controlled trials, the majority of guidelines for managing pCD are based on consensus of expert opinion. Much of the published literature focuses on medical management, leaving gaps in guidance for surgeons [4, 5] .
A multidisciplinary approach appears to improve quality of care for patients with CD [6] ; however, the medical and surgical approach to its management may differ. The recent Delphi exercise by the Bowel Disease Research Foundation and the Association of Coloproctology of Great Britain and Ireland (ACPGBI) has identified the management of pCD as an area requiring further research [7] . Using the established surgical research collaboratives [8] we sought to identify variations in current surgical management of this debilitating condition.
The aim of this study was to report current colorectal practice in the surgical management of pCD in the United Kingdom (UK).
Method
The survey was devised by a group of surgeons and gastroenterologists with an interest in inflammatory bowel disease (IBD), and further assessed and altered by patient consultation. The questionnaire was designed to audit practice in four areas: assessment and management of acute presentation, assessment and management of elective presentation, multidisciplinary management and definitive surgical management. Questionnaires were anonymous at the respondent level.
The questions asked are included in Tables 1-5 shown in the Results. The survey was designed so that responses were either binary (yes/no), a frequency using a four point scale (always, sometimes, occasionally, never) or a selection of options from a menu. Where options were provided, instructions of 'select one' or 'select as many as apply' were clear, with an 'other' option provided.
A pilot of the survey was undertaken at the July 2015 meeting of the Digestive Disorders Federation in London, with instructions to complete the survey and to offer a critique of questions where appropriate. Following the critique of the questionnaire, minor clarifications were made to the wording of two questions, the option set was changed for two questions to widen the range of timing options and one additional option was included in a question on treatment.
The full questionnaire was run through the UK surgical trainee research collaboratives, led jointly by the South Yorkshire Surgical Research Group (SYSuRG) and the North-West Research Collaborative (NWRC). Collaborators were asked to deliver the questionnaire to consultant colorectal surgeons in their units. Initial contact was made via the National Research Collaborative email lists and electronic contact to local collaborative leads was cascaded locally. Collaborators were asked to support delivery of hard-copy questionnaires locally to consultants and return at least three completed questionnaires to the Research Electronic Data Capture TM (REDCap) system, hosted by the University of Sheffield [9] . Although questionnaires were anonymous at respondent level, the number of centres and participants included was recorded by collaborators.
Numerical data from the questionnaire were collated and presented in a descriptive manner only. Where binary answers were changed to four-point answers for the final study, yes and no options were analysed as 'always' and 'never' responses respectively. Free text data on indications for stoma and proctectomy were collated and representative statements reported.
Ethical approval was not required for service evaluation of current practice. 
Acute management of perianal sepsis
This section addressed patients admitted acutely with perianal symptoms. There was variation in the use of perioperative antibiotics in the acute setting, with 39.6% of respondents always using them and 5.8% never using them. Most respondents (42.2%) would start antibiotic therapy preoperatively on the ward or in clinic, with 40.9% starting therapy at induction of anaesthesia. The antibiotic of choice was metronidazole (77.9%), followed by co-amoxiclav (35.1%) and ciprofloxacin (20.1%). Few respondents would always ask for preoperative imaging in the acute setting (7.1%), but the majority would seek imaging frequently (37.0%) or occasionally (51.9%). Where imaging was used, magnetic resonance imaging (MRI) of the pelvis was the preferred modality (96.1%), with a small minority using endoanal ultrasound (2.5%) or CT (1.9%).
Where the diagnosis of Crohn's disease was suspected but not yet established, respondents were asked to report which investigations they would use to confirm or refute this. Faecal calprotectin was routinely Crohn's fistula in an acute setting
We asked respondents to identify which procedures they would routinely consider in an operation for an acutely symptomatic/emergency presentation of pCD; 32% would drain sepsis, 31.1% would consider placement of a draining seton if appropriate and 0.6% would consider excision of the fistula track. The majority of respondents (89.6%) indicated that they would never consider a cutting seton in this setting (Table 2) .
Respondents reported on what advice they would give to a less experienced surgeon (a general surgical colleague or registrar) undertaking surgery in this setting. Responses tended to recommend a more conservative approach, with 43.5% advocating drainage of sepsis, 19.5% advocating placement of a draining seton and 94.8% advising against a cutting seton. Free text comments from two respondents indicated a feeling that only an experienced colorectal surgeon should be undertaking these procedures.
Subsequent elective surgery
The survey elicited procedural preferences for the first subsequent elective examination under anaesthetic (EUA). As in the acute setting, draining seton was routinely considered (66.6%) and cutting seton was avoided (84.4%). Where preferences were indicated, Ethibond 16 .5% of respondents, although 75.9% of respondents indicated that they would frequently or occasionally undertake repeated EUA, suggesting a 'selected case' approach. Postoperative antibiotics were routinely used by 11.2% of respondents, and in selected cases (frequently/occasionally) by 75.0% (Table 3) .
Medical and multimodal management of pCD
An inflammatory bowel disease multidisciplinary team (MDT) was available to 87.6% of respondents. Of these, 25.1% routinely discussed all cases of pCD in this setting and only 0.7% of respondents never discussed patients. A multimodal approach utilizing joint medical and surgical therapy was routinely used by 28.6% of respondents, with just 1.9% not using a combined approach (Table 4) .
Gastroenterology follow-up was arranged for all patients by 71.4% of respondents. Immunosuppressant therapy was routinely used in treatment of this condition by 32.8% of respondents, with 58.8% indicating a selected-case approach. Eight responses were excluded from this analysis as their response from the pilot survey could not be mapped to the final questionnaire.
Surgeons were asked to identify which drug(s) they would prefer a patient to receive as part of multimodal care. Anti-tumour necrosis factor-alpha (anti-TNF-a) therapy was most frequently preferred (64.2%), followed by azathioprine (33.7%). Despite expressing preferences, 42.2% of surgeons left the final decision on medical management to a gastroenterologist. A summary of the results is presented in Table 4 .
The decision on seton removal was made by surgeons in 64.2% of cases, the MDT in 33.7% of cases and by gastroenterologists in 5.8% of cases. The patient made the decision for seton removal in 4.5% of responses. A free-text option was available to report the timing of seton removal. Responses indicated that this was highly variable and tailored to the patient. In some cases, timings were related to surgery, e.g. 3 months postoperatively, and in others related to biological therapy, e.g. after the third dose. Respondents also indicated that it might be left in situ indefinitely.
Definitive surgical management of pCD
Eleven surgical procedures were considered by respondents as options to facilitate definitive closure of a fistula. The most frequently considered options were removal of the seton only (70.7%), fistulotomy (57.1%), advancement flap (38.9%), fistula plug (36.4%) and ligation of intersphincteric track (LIFT) procedure (31.8%). Fistulectomy (27.9%), fibrin glue (12.9%) and local perineal flaps (7.8%) were used by fewer respondents. Early adopters of technology indicated use of over the scope clip (OTSC) (1.2%), video-assisted fistula closure (VAAFT) (1.9%) and fistula-assisted laser closure (FiLaC TM ) (0.6%). Most respondents used diverting stoma and proctectomy on a selected-case basis, with only 12.3% of respondents never using a stoma and 12.9% never considering proctectomy. Free-text responses defining indications for these were similar with the phrase 'failed bottom' used by many respondents. This was defined as recurrent or chronic perianal sepsis, incontinence and symptoms or proctitis refractory to medical therapy. Dysplasia and malignancy were reported as specific indications for proctectomy. Patient choice was identified by several respondents as a factor in their decision to undertake these procedures. Where proctectomy was performed, a small perineal defect would be primarily closed, but respondents preferred flap-based perineal reconstruction if a large defect remained.
A significant minority (41.5%) of respondents indicated that they would treat rectovaginal fistula. This group of respondents would use definitive procedures including advancement flap (21.5%), fistula plug (10.9%), Martius flap (9.3%), omental interposition (6.2%) and the LIFT procedure (4.6%) to treat rectovaginal fistula. A diverting stoma would be used by 6.2% of respondents. A summary of definitive options used in perianal and rectovaginal fistulas are presented in Table 5 .
Discussion
This study has used a collaborative approach to assess current UK surgical practice in pCD. It has identified areas of common practice, including choice of imaging modality, antibiotics and avoidance of sphincter-disrupting treatments such as a cutting seton. The survey has clearly exposed variation in practice in the management of pCD.
There are limitations associated with survey-based research, including responder bias. We attempted to address these in the study design by using personal contacts and trainee-consultant relationships with the opportunity for case-based discussions rather than impersonal electronic surveys with attendant poor response rates. Mitigation against survey fatigue due to length of the questionnaire was also evident in the engagement of local collaborators to deliver and complete the questionnaire. Anonymous participation in the survey may also have helped improve the response rates, as there was no concern about identification or challenge related to practice. The high response rate was achieved with the support of the trainee collaborative networks. IBD, inflammatory bowel disease; MDT, multidisciplinary team; pCD, fistulating perianal Crohn's disease; Anti-TNF-a, antitumour necrosis factor-alpha. *Selected cases group was split into 'Frequently' and 'Occasionally' after the pilot. †Percentage based on 143 respondents who replied 'Yes' to IBD MDT or missing responses (i.e. excludes those with no MDT). ‡Eight patients were excluded as the option 'selected cases' was removed in the full version.
Management of a condition with variable presentations and degrees of severity such as pCD will inevitably lead to some difficulties in achieving clear agreement around routine practice because management is rightly tailored to each case. This is reflected by the high proportion of respondents who selected 'frequently' or 'occasionally' as options.
There is little evidence on the use of antibiotics alone in the treatment of pCD, with meta-analyses on the use of ciprofloxacin suggesting a marginal effect in remission [10, 11] . In combination with adalimumab, it may offer additional benefit in healing [12] . Recent American guidelines suggest that antibiotics in perianal sepsis might be of benefit only in immunosuppressed patients, or where there is systemic upset or cellulitis [13] .
MRI is well established as the imaging modality of choice in pCD, and has been used to guide therapy in one study [14] . Endo-anal ultrasound is not yet a widely used technology. It has a niche role here as a diagnostic adjunct in specialist hands [15] , but has limitations depending on the type of fistula present [16] .
Surgeons used a variety of investigations for establishing the diagnosis of Crohn's disease. Faecal calprotectin is a sensitive marker of mucosal inflammation, so may be raised in a number of non-Crohn's related scenarios [17, 18] . Endoscopic assessment allows visual and histological assessment of the colon. The split between colonoscopy and flexible sigmoidoscopy may be associated with surgeons just ruling out proctitis rather than assessing the whole colon, as proctitis is a prognostic factor in mucosal healing [4] and also in persistence of fistula.
The roles of anti-TNF-a therapy and azathioprine are well established in this setting, so their positions as drugs of choice are merited [12, 14, 19] . Previous work has demonstrated that steroids should not be used for pCD alone, and their use in this setting runs counter to current guidelines [4, 20] . The use of steroids to treat associated luminal disease may be appropriate, and it is possible that this factor was considered when responding to questions about the best medical therapy [20] .
In both acute and initial elective settings, the survey shows a tendency towards conservative and sphincterpreserving procedures, in the form of drainage of sepsis and use of a draining seton. Respondents widely rejected the use of cutting setons in this group of patients. Patients with pCD tend to a chronic and recurrent disease course necessitating multiple interventions, and therefore efforts should be made to preserve continence where possible [21] . The conservative advice given to less experienced surgeons suggests that UK practice is aimed at avoiding iatrogenic exacerbation of fistulating disease and tends to favour management by experienced colorectal surgeons.
The timing of seton removal varied with treatment intent, although in free text comments respondents indicated that they tended to follow one of two published UK practices [14, 22] . The perceived advantage of early removal of a seton is the removal of a 'splint' maintaining patency of a fistula and allowing it to heal. The trade-off is that removal too early in the treatment process might promote recurrent perianal sepsis.
There are a wide range of procedures offered as definitive surgical options for patients with pCD. Draining seton alone, fistulotomy, fistula plug and LIFT have been described in the literature, with varying outcomes, although this is mostly on the basis of observational and not trial-based data [21, 23, 24] . The variety of choice in definitive surgery may reflect in part a lack of consensus and limited evidence for the surgical management of pCD, but may also be influenced by the expertise of individual surgeons.
Much of the recent literature has focused on a multimodal approach to pCD, with emphasis on sepsis control and institution of medical therapy (e.g. biologicals) to aid fistula closure showing benefit over surgery alone [25, 26] . Current trials are investigating various permutations of this approach [27] . It is encouraging that most respondents have access to an IBD MDT and utilize immunosuppressant drugs as part of their therapy, although only 28% routinely employ this approach. This study did not explore the make-up of IBD MDTs or whether MDTs were supported at a local or regional level. This study reported that some surgeons do not undertake proctectomy or stoma formation, or manage Crohn's rectovaginal fistula. In light of the varied definitive options described, it is possible that a number of surgeons will simply place a seton and not offer any surgical options beyond that, perhaps preferring to refer on to specialist colleagues. Single-centre experience with rectovaginal fistula, even in tertiary or quaternary centres, comes from small cohorts [28, 29] . As volume is associated with outcome in some aspects of colorectal surgery [30] , perhaps centralization of definitive surgery for pCD should be considered. This might offer better outcomes, but at the risk of losing local expertise in peripheral hospitals [31] . Those who do undertake proctectomy or stoma formation broadly agreed on indications for these procedures. It is of note that patient preference or request was a recognized indication, as quality of life in patients with pCD has been found to be improved in patients who have a stoma [32] .
Conclusion
This study reports on individual surgical approaches to pCD in the context of trends in national practice. Variations in practice will have implications for the design of and implementation of future research interventions in pCD. Further work is required to reach consensus on standardization of the pCD management pathway. In the interim, early and efficient control of sepsis, multimodal pCD management and an emphasis on sphincter-preserving surgical techniques are the current foundations of managing pCD in the UK.
